Cited by 3,481Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and SignalingDeep Brain Stimulation and Movement Disorders

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Open access

Gibb, W R, Lees, A J·1988·Journal of Neurology, Neurosurgery & Psychiatry

DOI 10.1136/jnnp.51.6.745PMC PMC1033142

Open this paper in CoChat — free account Open PDF

Abstract

The Lewy body is a distinctive neuronal inclusion that is always found in the substantia nigra and other specific brain regions in Parkinson's disease. It is mainly composed of structurally altered neurofilament, and occurs wherever there is excessive loss of neurons. It occurs in some elderly individuals and rarely in other degenerative diseases of the central nervous system. In 273 brains of patients dying from disorders other than Parkinson's disease, the age-specific prevalence of Lewy bodies increased from 3.8% to 12.8% between the sixth and ninth decades. Associated pathological findings suggest that these cases of incidental Lewy body disease are presymptomatic cases of Parkinson's disease, and confirm the importance of age (time) in the evolution of the disease. In view of the common and widespread occurrence of this disorder we propose that endogenous mechanisms operating in early life may be more important than environmental agents in the pathogenesis of Lewy bodies and Parkinson's disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/jnnp.51.6.745

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations
Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K. A., & SEITELBERGER, F. (1973) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(73)90175-5 · Cited by 2,650
Basal forebrain neurons in the dementia of Parkinson disease
Whitehouse, P. J., Hedreen, J. C., White, C. L., & Price, D. L. (1983) · Annals of Neurology · doi:10.1002/ana.410130304 · Cited by 535
AETIOLOGY OF PARKINSON'S DISEASE
Calne, D., & Langston, J. W. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90802-4 · Cited by 469
Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease?
Kosaka, K., Yoshimura, M., Ikeda, K., & Budka, H. (1984) · PubMed · Cited by 401
Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeys
Forno, L. S., Langston, J. W., DeLanney, L. E., Irwin, I., & Ricaurte, G. A. (1986) · Annals of Neurology · doi:10.1002/ana.410200403 · Cited by 351
Parkinson's disease in 65 pairs of twins and in a set of quadruplets
Ward, C. D., Duvoisin, R. C., Ince, S. E., Nutt, J., Eldridge, R., & Calne, D. B. (1983) · Neurology · doi:10.1212/wnl.33.7.815 · Cited by 347
PHASE AND ELECTRON MICROSCOPIC OBSERVATIONS OF LEWY BODIES AND MELANIN GRANULES IN THE SUBSTANTIA NIGRA AND LOCUS CAERULEUS IN PARKINSONʼS DISEASE
Duffy, P. E., & Tennyson, V. M. (1965) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-196507000-00003 · Cited by 345
THE SIGNIFICANCE OF THE LEWY BODY IN THE DIAGNOSIS OF IDIOPATHIC PARKINSON'S DISEASE
Gibb, W. R. G., & Lees, A. J. (1989) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1989.tb01147.x · Cited by 325
Self-citation
Esophageal Lewy bodies associated with ganglion cell loss in achalasia
Qualman, S. J., Haupt, H. M., Yang, P. H., & Hamilton, S. R. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90079-9 · Cited by 305
Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease.
Qualman, S. J., Haupt, H. M., Yang, P. H., & Hamilton, S. R. (1984) · PubMed · Cited by 295

Flagged first, then by citations

Show all 39 references

Research works printed but not linked: 7

Gibb WRG. The Lewy body and Parkinson's disease. In: Clifford Rose F, ed. Parkinson's Disease: Clinical and Experimental Advances. London: John Libbey and Co, 1987:3-11.
Oppenheimer D. Neuropathology of progressive autonomic failure. In: Bannister R, ed. Autonomic failure. Oxford University Press, London, 1983:267-83.
Sigwald J, Lapresle J, Raverdy P, Recondo NJ. Atrophie cerebelleuse familiale avec association de lesions nigeriennes et spinales. Presse Med 1964;72:557-62.
Vogt C, Vogt 0. Erkrankungen der GroBhirnrinde im Lichte der Topistik, Pathoklise und Pathoarchitektonik. J Psychol Neurol 1922;28:1-171.
Hamada S, Ishii T. The Lewy body in the brain of the aged. Adv Neurol Sci 1963;7:184-6.
Hirai S. Ageing of the substantia nigra. Adv Neurol Sci 1968;12:845-9.
Hassler R. Zur Pathologie der Paralysis agitans und des postenzephalitischen Parkinsonismus. J Psychol Neurol 1938;48:387-476.

Sorted by citations

Items 101–200 of 1,022

Review: Sporadic Parkinson's disease: development and distribution ofα‐synuclein pathology
Tredici, K. D., & Braak, H. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12298 · Cited by 416
Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder
Postuma, R. B., Lang, A. E., Massicotte-Marquez, J., & Montplaisir, J. Y. (2006) · Neurology · doi:10.1212/01.wnl.0000203648.80727.5b · Cited by 392
REM sleep behavior disorder and degenerative dementia
Boeve, B. F., Silber, M. H., Ferman, T. J., Kokmen, E., Smith, G. E., Ivnik, R. J., Parisi, J. E., Olson, E. J., & Petersen, R. C. (1998) · Neurology · doi:10.1212/wnl.51.2.363 · Cited by 395
Parkinson's disease: Autoimmunity and neuroinflammation
VIRGILIO, A. D., Greco, A., Fabbrini, G., Inghilleri, M., Rizzo, M. I., Gallo, A., Conte, M., Rosato, C., Appiani, M. C., & VINCENTIIS, M. D. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.07.022 · Cited by 397
Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis
Zijlmans, J. C. M., Daniel, S. E., Hughes, A. J., Révész, T., & Lees, A. J. (2004) · Movement Disorders · doi:10.1002/mds.20083 · Cited by 381
Self-citation
APOE ϵ4 Increases Risk for Dementia in Pure Synucleinopathies
Tsuang, D., Leverenz, J. B., Lopez, O. L., Hamilton, R. L., Bennett, D. A., Schneider, J. A., Buchman, A. S., Larson, E. B., Crane, P. K., Kaye, J. A., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.600 · Cited by 378
Echogenicity of the Substantia Nigra
Berg, D., Roggendorf, W., Schroeder, U., Klein, R., Tatschner, T., Benz, P. M., Tucha, O. M., Preier, M., Lange, K. W., Reiners, K., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.6.999 · Cited by 381
Safety and Efficacy of Focused Ultrasound Thalamotomy for Patients With Medication-Refractory, Tremor-Dominant Parkinson Disease
Bond, A. E., Shah, B., Huss, D., Dallapiazza, R. F., Warren, A., Harrison, M. B., Sperling, S. A., Wang, X.-Q., Gwinn, R. P., Witt, J., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.3098 · Cited by 391
Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease
Dickson, D. W., Fujishiro, H., DelleDonne, A., Menke, J., Ahmed, Z., Klos, K. J., Josephs, K. A., Frigerio, R., Burnett, M., Parisi, J. E., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0345-7 · Cited by 364
Prevalence of orthostatic hypotension in Parkinson's disease
Sénard, J., Rai, S., Lapeyre‐Mestre, M., Brefel‐Courbon, C., Rascol, O., Rascol, A., & Montastruc, J. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.5.584 · Cited by 365
Effect of levodopa on pain threshold in Parkinson's disease: A clinical and positron emission tomography study
Brefel‐Courbon, C., Payoux, P., Thalamas, C., Ory‐Magne, F., Quelven, I., Chollet, F., Montastruc, J. L., & Rascol, O. (2005) · Movement Disorders · doi:10.1002/mds.20629 · Cited by 365
Cannabidiol for the treatment of psychosis in Parkinson's disease
Zuardi, A., Crippa, J., Hallak, J., Pinto, J., Chagas, M., Rodrigues, G., Dursun, S., & Tumas, V. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108096519 · Cited by 355
Parkin disease: a phenotypic study of a large case series
Khan, N. L., Graham, E., Critchley, P., Schrag, A. E., Wood, N. W., Lees, A. J., Bhatia, K. P., & Quinn, N. P. (2003) · Brain · doi:10.1093/brain/awg142 · Cited by 352
Self-citation
Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease
Pearce, R. K. B., Owen, A., Daniel, S. E., Jenner, P. G., & MARSDEN, C. D. (1997) · Journal of Neural Transmission · doi:10.1007/bf01291884 · Cited by 350
Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease
Lees, A. J. (1995) · BMJ · doi:10.1136/bmj.311.7020.1602 · Cited by 346
Self-citation
Is freezing of gait in Parkinson's disease related to asymmetric motor function?
Plotnik, M., Giladi, N., Balash, Y., Peretz, C., & Hausdorff, J. M. (2005) · Annals of Neurology · doi:10.1002/ana.20452 · Cited by 344
Assessment of cognition in Parkinson’s disease
Marinus, J., Jeukens‐Visser, M., Verwey, N. A., Verhey, F. R. J., Middelkoop, H. A. M., Stiggelbout, A. M., & van Hilten, J. J. (2003) · Neurology · doi:10.1212/01.wnl.0000091864.39702.1c · Cited by 340
Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial
Katzenschlager, R., Poewe, W. H., Rascol, O., Trenkwalder, C., Deuschl, G., Chaudhuri, К. R., Henriksen, T., van Laar, T., Spivey, K., Vel, S., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30239-4 · Cited by 339
Self-citation
Visual control of locomotion in Parkinson's disease
Azulay, J., Mesure, S., Amblard, B., Blin, O. J., Sangla, I., & Pouget, J. (1999) · Brain · doi:10.1093/brain/122.1.111 · Cited by 338
Ferroptosis and cell death mechanisms in Parkinson's disease
Guiney, S. J., Adlard, P. A., Bush, A. I., Finkelstein, D. I., & Ayton, S. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.01.004 · Cited by 353
Diagnosis and Initial Management of Parkinson's Disease
Nutt, J. G., & Wooten, G. F. (2005) · New England Journal of Medicine · doi:10.1056/nejmcp043908 · Cited by 337
Dopamine Transporter Loss Visualized With FP-CIT SPECT in the Differential Diagnosis of Dementia With Lewy Bodies
O'Brien, J. T., Colloby, S. J., Fenwick, J., Williams, E. D., Firbank, M., Burn, D. J., Aarsland, D., & McKeith, I. G. (2004) · Archives of Neurology · doi:10.1001/archneur.61.6.919 · Cited by 333
Alzheimer Disease With Amygdala Lewy Bodies: A Distinct Form of α-Synucleinopathy
Uchikado, H., Lin, W.-L., DeLucia, M. W., & Dickson, D. W. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000225908.90052.07 · Cited by 359
The EQ-5D---a generic quality of life measure---is a useful instrument to measure quality of life in patients with Parkinson's disease
Schrag, A. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.1.67 · Cited by 327
Paraquat exposure as an etiological factor of Parkinson's disease
Dinis‐Oliveira, R. J., Remião, F., Carmo, H., Duarte, J. A., Navarro, A. S., Bastos, M. D. L., & Carvalho, F. D. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.05.012 · Cited by 337
Pattern of brain destruction in Parkinson's and Alzheimer's diseases
Braak, H., Braak, E., Yilmazer‐Hanke, D., de Vos, R. A. I., Jansen, E. N. H., & Böhl, J. (1996) · Journal of Neural Transmission · doi:10.1007/bf01276421 · Cited by 326
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease
Tessitore, A., Esposito, F., Vitale, C., Santangelo, G., Amboni, M., Russo, A., Corbo, D., Cirillo, G., Barone, P., & Tedeschi, G. (2012) · Neurology · doi:10.1212/wnl.0b013e31827689d6 · Cited by 326
Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease
Gagnon, J., Vendette, M., Postuma, R. B., Desjardins, C., Massicotte-Marquez, J., Panisset, M., & Montplaisir, J. Y. (2009) · Annals of Neurology · doi:10.1002/ana.21680 · Cited by 339
The Neuropathology of Huntington’s Disease
Waldvogel, H. J., Kim, E. H., Tippett, L. J., Vonsattel, J., & Faull, R. L. M. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_354 · Cited by 327
Loss of apolipoprotein E receptor LR11 in Alzheimer disease
Scherzer, C. R., Offe, K., Gearing, M., Rees, H. D., Fang, G., Heilman, C. J., Schaller, C., Bujo, H., Levey, A. I., & Lah, J. J. (2004) · Archives of Neurology · doi:10.1001/archneur.61.8.1200 · Cited by 316
Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study
Katzenschlager, R. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.028761 · Cited by 321
Olfactory Dysfunction as an Early Biomarker in Parkinson’s Disease
Fullard, M. E., Morley, J. F., & Duda, J. E. (2017) · Neuroscience Bulletin · doi:10.1007/s12264-017-0170-x · Cited by 321
Word processing in Parkinson's disease is impaired for action verbs but not for concrete nouns
Véronique Boulenger, A., Mechtouff, L., Thobois, S., Broussolle, E., Jeannerod, M., & Nazir, T. A. (2007) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2007.10.007 · Cited by 344
Parkinson’s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons
Braak, H., Sastre, M., Böhl, J., de Vos, R. A. I., & Tredici, K. D. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0193-x · Cited by 325
α‐Synuclein and Parkinson's disease
Recchia, A., Debetto, P., Negro, A., Guidolin, D., Skaper, S. D., & Giusti, P. (2004) · The FASEB Journal · doi:10.1096/fj.03-0338rev · Cited by 331
Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data
Khan, N. L., Jain, S., Lynch, J. M., Pavese, N., Abou‐Sleiman, P. M., Holton, J. L., Healy, D. G., Gilks, W. P., Sweeney, M. G., Ganguly, M., et al. (2005) · Brain · doi:10.1093/brain/awh667 · Cited by 317
Self-citation
Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease
Dexter, D. T., Sian, J., Rose, S., Hindmarsh, J. G., Mann, V. M., Cooper, J. A. D., Wells, F. R., Daniel, S. E., Lees, A. J., Schapira, A. H. V., et al. (1994) · Annals of Neurology · doi:10.1002/ana.410350107 · Cited by 317
Self-citation
α‐Synuclein pathology does not predict extrapyramidal symptoms or dementia
Parkkinen, L., Kauppinen, T., Pirttilä, T., Autere, J. M., & Alafuzoff, I. I. (2004) · Annals of Neurology · doi:10.1002/ana.20321 · Cited by 328
Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom
Hobson, P., & Meara, J. (2004) · Movement Disorders · doi:10.1002/mds.20216 · Cited by 312
Validation of the MDS clinical diagnostic criteria for Parkinson's disease
Postuma, R. B., Poewe, W., Litvan, I., Lewis, S., Lang, A. E., Halliday, G., Goetz, C. G., Chan, P., Slow, E., Seppi, K., et al. (2018) · Movement Disorders · doi:10.1002/mds.27362 · Cited by 283
Oral Anticoagulant Therapy in Patients With Coronary Artery Disease: A Meta-analysis
Anand, S. S. (1999) · JAMA · doi:10.1001/jama.282.21.2058 · Cited by 311
Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease
Burn, D. J., Emre, M., McKeith, I. G., Deyn, P. P. D., Aarsland, D., Hsu, C., & Lane, R. M. (2006) · Movement Disorders · doi:10.1002/mds.21077 · Cited by 310
S erum immune markers and disease progression in an incident P arkinson's disease cohort ( ICICLE‐PD )
Williams‐Gray, C. H., Wijeyekoon, R., Yarnall, A. J., Lawson, R. A., Breen, D. P., Evans, J., Cummins, G. A., Duncan, G. W., Khoo, T. K., Burn, D. J., et al. (2016) · Movement Disorders · doi:10.1002/mds.26563 · Cited by 310
Prevalence of movement disorders in men and women aged 50–89 years (Bruneck Study cohort): a population-based study
Wenning, G. K., Kiechl, S., Seppi, K., Müller, J., Högl, B., Saletu, M., Rungger, G., Gasperi, A., Willeit, J., & Poewe, W. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70226-x · Cited by 302
Pharmacologically modulated fMRI---cortical responsiveness to levodopa in drug‐naive hemiparkinsonian patients
Buhmann, C., Glauche, V., Stürenburg, H. J., Oechsner, M., Weiller, C., & Büchel, C. (2003) · Brain · doi:10.1093/brain/awg033 · Cited by 305
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease
Brundin, P. (2000) · Brain · doi:10.1093/brain/123.7.1380 · Cited by 303
Lewy-body formation is an aggresome-related process: a hypothesis
Olanow, C. W., Perl, D. P., Demartino, G., & McNaught, K. S. P. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00827-0 · Cited by 312
Tremor in Parkinson’s disease and serotonergic dysfunction
Doder, M., Rabiner, E. A., Turjanski, N., Lees, A. J., & Brooks, D. J. (2003) · Neurology · doi:10.1212/01.wnl.0000031424.51127.2b · Cited by 302
Self-citation
Freezing of gait and executive functions in patients with Parkinson's disease
Amboni, M., Cozzolino, A., Longo, K., Picillo, M., & Barone, P. (2007) · Movement Disorders · doi:10.1002/mds.21850 · Cited by 302
Visual perception in Parkinson disease dementia and dementia with Lewy bodies
Mosimann, U. P., Mather, G., Wesnes, K. A., O'Brien, J. T., Burn, D. J., & McKeith, I. G. (2004) · Neurology · doi:10.1212/01.wnl.0000145764.70698.4e · Cited by 299
Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell
Berendse, H. W., Booij, J., Francot, C. M. J. E., Bergmans, P., Hijman, R., Stoof, J. C., & Wolters, E. C. (2001) · Annals of Neurology · doi:10.1002/ana.1049 · Cited by 298
Accuracy of the Clinical Diagnoses of Lewy Body Disease, Parkinson Disease, and Dementia With Lewy Bodies
Litvan, I., MacIntyre, A. T., Goetz, C. G., Wenning, G. K., Jellinger, K. A., Verny, M., Bartko, J. J., Jankovic, J. J., McKee, A. C., Brandel, J., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.7.969 · Cited by 299
Amygdala pathology in Parkinson's disease
Braak, H., Braak, E., Yilmazer‐Hanke, D., de Vos, R. A. I., Jansen, E. N. H., Böhl, J., & Jellinger, K. A. (1994) · Acta Neuropathologica · doi:10.1007/bf00296485 · Cited by 297
Glutathione‐related enzymes in brain in Parkinson's disease
Sian, J., Dexter, D. T., Lees, A. J., Daniel, S. E., Jenner, P. G., & MARSDEN, C. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360306 · Cited by 296
Self-citation
The relationship of essential tremor to other movement disorders: Report on 678 patients
Koller, W. C., Busenbark, K. L., Miner, K., & The Essential Tremor Study Group (1994) · Annals of Neurology · doi:10.1002/ana.410350613 · Cited by 293
The Concept of Prodromal Parkinson’s Disease
Mahlknecht, P., Seppi, K., & Poewe, W. H. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-150685 · Cited by 315
Quantitative measurement of pain sensation in patients with Parkinson disease
Djaldetti, R., Shifrin, A., Rogowski, Z., Sprecher, E., Melamed, E., & Yarnitsky, D. (2004) · Neurology · doi:10.1212/01.wnl.0000130455.38550.9d · Cited by 290
Polysomnographic diagnosis of idiopathic REM sleep behavior disorder
Montplaisir, J. Y., Gagnon, J., Fantini, M. L., Postuma, R. B., Dauvilliers, Y. A., Désautels, A., Rompré, S., & Paquet, J. (2010) · Movement Disorders · doi:10.1002/mds.23257 · Cited by 289
Chronic pain in Parkinson's disease: The cross‐sectional French DoPaMiP survey
Negre-pages, L., Regragui, W., Bouhassira, D., Grandjean, H., & Rascol, O. (2008) · Movement Disorders · doi:10.1002/mds.22142 · Cited by 296
Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single‐dose challenges
Katzenschlager, R., Hughes, A. J., Evans, A. H., Manson, A. J., Hoffman, M., Swinn, L., Watt, H., Bhatia, K. P., Quinn, N. P., & Lees, A. J. (2004) · Movement Disorders · doi:10.1002/mds.20276 · Cited by 286
Self-citation
Meta-analysis of Parkinson disease: Identification of a novel locus, RIT2
Pankratz, N., Beecham, G., Destefano, A., Dawson, T. M., Doheny, K., Factor, S., Hamza, T., Hung, A. Y., Hyman, B., Ivinson, A., et al. (2012) · Annals of Neurology · doi:10.1002/ana.22687 · Cited by 309
REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia
Vendette, M., Gagnon, J., Décary, A., Massicotte-Marquez, J., Postuma, R. B., Doyon, J., Panisset, M., & Montplaisir, J. Y. (2007) · Neurology · doi:10.1212/01.wnl.0000278114.14096.74 · Cited by 284
Patient-reported autonomic symptoms in Parkinson disease
Verbaan, D., Marinus, J., Jeukens‐Visser, M., van Rooden, S. M., Stiggelbout, A. M., & van Hilten, J. J. (2007) · Neurology · doi:10.1212/01.wnl.0000266593.50534.e8 · Cited by 283
The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson’s disease
Maillet, A., Krack, P., Lhommée, E., Météreau, É., Klinger, H., Favre, É., Bars, D. L., Schmitt, E., Bichon, A., Pélissier, P., et al. (2016) · Brain · doi:10.1093/brain/aww162 · Cited by 300
Phosphorylated α-Synuclein in Parkinson’s Disease
Wang, Y., Shi, M. Y., Chung, K. A., Zabetian, C. P., Leverenz, J. B., Berg, D., Srulijes, K., Trojanowski, J. Q., Lee, V. M. ‐., Siderowf, A. D., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3002566 · Cited by 307
Post-stroke movement disorders: report of 56 patients
Alarcón, F. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.011874 · Cited by 280
Aggresome‐related biogenesis of Lewy bodies
McNaught, K. S. P., Shashidharan, P., Perl, D. P., Jenner, P. G., & Olanow, C. W. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02301.x · Cited by 279
Proteasomal inhibition leads to formation of ubiquitin/α‐synuclein‐immunoreactive inclusions in PC12 cells
Rideout, H. J., Larsen, K. E., Sulzer, D., & Stefanis, L. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00474.x · Cited by 283
Sequential bilateral transplantation in Parkinson's disease: Effects of the second graft
Hagell, P. (1999) · Brain · doi:10.1093/brain/122.6.1121 · Cited by 274
Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study
Devos, D., Dujardin, K., Poirot, I., Moreau, C., Cottencin, O., Thomas, P., Destée, A., Bordet, R., & Defebvre, L. (2008) · Movement Disorders · doi:10.1002/mds.21966 · Cited by 273
Magnetic resonance imaging for the diagnosis of Parkinson’s disease
Heim, B., Krismer, F., De Marzi, R., & Seppi, K. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1717-8 · Cited by 272
Aging Produces a Specific Pattern of Striatal Dopamine Loss: Implications for the Etiology of Idiopathic Parkinson's Disease
Kish, S. J., Shannak, K. S., Rajput, A. H., Deck, J. H. N., & Hornykiewicz, O. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09766.x · Cited by 272
What best differentiates Lewy body from Alzheimer's disease in early-stage dementia?
Tiraboschi, P., Salmon, D. P., Hansen, L. A., Hofstetter, R., Thal, L. J., & Corey‐Bloom, J. (2006) · Brain · doi:10.1093/brain/awh725 · Cited by 274
Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis
Wang, H.-F., Yu, J., Tang, S., Jiang, T., Tan, C.-C., Meng, X.-F., Wang, C., Tan, M., & Tan, L. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-307659 · Cited by 275
Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [18F]dopa-PET study
Rakshi, J. S., Uema, T., Ito, K., Bailey, D. L., Morrish, P., Ashburner, J., Dagher, A., Jenkins, I. H., Friston, K. J., & Brooks, D. J. (1999) · Brain · doi:10.1093/brain/122.9.1637 · Cited by 274
Accuracy of diagnosis in patients with presumed Parkinson's disease
Meara, J. (1999) · Age and Ageing · doi:10.1093/ageing/28.2.99 · Cited by 265
UCHL1 is a Parkinson's disease susceptibility gene
Maraganore, D. M., Lesnick, T. G., Elbaz, A., Chartier‐Harlin, M., Gasser, T., Krüger, R., Hattori, N., Mellick, G. D., Quattrone, A., Satoh, J., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20017 · Cited by 263
International study on the psychometric attributes of the Non-Motor Symptoms Scale in Parkinson disease
Martínez‐Martín, P., Rodríguez‐Blázquez, C., Abe, K., Bhattacharyya, K., Bloem, B. R., Carod-Artal, F. J., Prakash, R., Esselink, R. A. J., Falup‐Pecurariu, C., Gallardo, M., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c0d416 · Cited by 263
Assessment of Sleep and Sleepiness in Parkinson Disease
Marinus, J., Jeukens‐Visser, M., van Hilten, J. J., Lammers, G. J., & Stiggelbout, A. M. (2003) · SLEEP · doi:10.1093/sleep/26.8.1049 · Cited by 262
Presentation, diagnosis, and management of multiple system atrophy in Europe: Final analysis of the European multiple system atrophy registry
Köllensperger, M., Geser, F., Ndayisaba, J., Boesch, S., Seppi, K., Østergaard, K., Dupont, E., Cardozo, A., TOLOSA, E. S., Abele, M., et al. (2010) · Movement Disorders · doi:10.1002/mds.23192 · Cited by 259
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait
Tessitore, A., Amboni, M., Esposito, F., Russo, A., Picillo, M., Marcuccio, L., Pellecchia, M. T., Vitale, C., Cirillo, M., Tedeschi, G., et al. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.03.018 · Cited by 271
Prevalence and Severity of Gait Disorders in Alzheimer's and Non‐Alzheimer's Dementias
Allan, L. M., Ballard, C. G., Burn, D. J., & Kenny, R. A. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53552.x · Cited by 255
The neuropsychology handbook
Horton, A. M., & Wedding, D. (2008) · Cited by 256
Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome
Tatebe, H., Kasai, T., Ohmichi, T., Kishi, Y., Kakeya, T., Waragai, M., Kondo, M., Allsop, D., & Tokuda, T. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0206-8 · Cited by 265
The heterogeneity of idiopathic Parkinson's disease
Foltynie, T., Brayne, C., & Barker, R. A. (2002) · Journal of Neurology · doi:10.1007/pl00007856 · Cited by 254
Alpha‐synuclein in Lewy Body Disease and Alzheimer's Disease
Hashimoto, M., & Masliah, E. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00552.x · Cited by 254
Expanded and independent validation of the Movement Disorder Society–Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)
Martínez‐Martín, P., Rodríguez‐Blázquez, C., Álvarez, M., Arakaki, T., Bergareche‐Yarza, A., Chade, A. R., Garretto, N., Gershanik, O. S., Kurtis, M. M., Martínez‐Castrillo, J. C., et al. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6624-1 · Cited by 264
Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease
Lefaucheur, J., Drouot, X., von Raison, F., Ménard‐Lefaucheur, I., Césaro, P., & Nguyen, J. (2004) · Clinical Neurophysiology · doi:10.1016/j.clinph.2004.05.025 · Cited by 251
Evolving concepts on bradykinesia
Bologna, M., Paparella, G., Fasano, A. A., Hallett, M., & Berardelli, A. (2019) · Brain · doi:10.1093/brain/awz344 · Cited by 270
Gait Analysis in Parkinson’s Disease: An Overview of the Most Accurate Markers for Diagnosis and Symptoms Monitoring
di Biase, L., Santo, A. D., Caminiti, M. L., Liso, A. D., Shah, S. A., Ricci, L., & Lazzaro, V. D. (2020) · Sensors · doi:10.3390/s20123529 · Cited by 271
Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: A clinical and electrophysiological study
Schwingenschuh, P., Ruge, D., Edwards, M. J., Terranova, C., Katschnig, P., Carrillo, F., Silveira‐Moriyama, L., Schneider, S. A., Kägi, G., Palomar, F. J., et al. (2010) · Movement Disorders · doi:10.1002/mds.23019 · Cited by 248
Self-citation
Pramipexole versus sertraline in the treatment of depression in Parkinson’s disease
Barone, P., Scarzella, L., Marconi, R., Antonini, A., Morgante, F., Bracco, F., Zappia, M., Musch, B., & and the Depression/Parkinson Italian Study Group (2006) · Journal of Neurology · doi:10.1007/s00415-006-0067-5 · Cited by 247
Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (swedds)
Schneider, S. A., Edwards, M. J., Mir, P., Cordivari, C., Hooker, J., Dickson, J., Quinn, N., & Bhatia, K. P. (2007) · Movement Disorders · doi:10.1002/mds.21685 · Cited by 247
Effect of cognitive and motor tasks on postural stability in Parkinson's disease: A posturographic study
Marchese, R., Bove, M., & Abbruzzese, G. (2003) · Movement Disorders · doi:10.1002/mds.10418 · Cited by 246
Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy
Yoshita, M. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00278-5 · Cited by 244
Red flags for multiple system atrophy
Köllensperger, M., Geser, F., Seppi, K., Stampfer‐Kountchev, M., Sawires, M., Scherfler, C., Boesch, S., Mueller, J., Koukouni, V., Quinn, N. P., et al. (2008) · Movement Disorders · doi:10.1002/mds.21992 · Cited by 244
Patterns and stages of α-synucleinopathy
ZACCAI, J. H., Brayne, C., McKeith, I. G., Matthews, F. E., & Ince, P. G. (2008) · Neurology · doi:10.1212/01.wnl.0000306697.48738.b6 · Cited by 249
Clinical and [18F] dopa PET findings in early Parkinson's disease.
Morrish, P., Sawle, G. V., & Brooks, D. J. (1995) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.59.6.597 · Cited by 244
Diagnostic Criteria for Parkinson’s Disease: From James Parkinson to the Concept of Prodromal Disease
Marsili, L., Rizzo, G., & Colosimo, C. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00156 · Cited by 262
Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial Parkinsonism associated with mutations in the Parkin gene
Hilker, R., Klein, C., Ghaemi, M., Kis, B., Strotmann, T., Ozelius, L. J., Lenz, O., Vieregge, P., Herholz, K., Heiss, W., et al. (2001) · Annals of Neurology · doi:10.1002/ana.74 · Cited by 244

Authors: Gibb, W. R., & Lees, A. J.
ORCID: Gibb, W R
Lees, A J
Venue: Journal of Neurology, Neurosurgery & Psychiatry
Publisher: BMJ
Published: 1988-06-01
Volume: 51
Issue: 6
Pages: 745-752
ISSN: 0022-3050 (ISSN-L)
DOI: 10.1136/jnnp.51.6.745
PMC: PMC1033142
OpenAlex: W2132881915
Semantic Scholar: 354cd1cf28ad23a8038bb3c576ff7791b3c74543
Cited by: 3,481
References: 39
Citations by year: 2026: 78 · 2025: 130 · 2024: 152 · 2023: 143 · 2022: 131 · 2021: 158 · 2020: 164 · 2019: 152 · 2018: 138 · 2017: 156 · 2016: 163 · 2015: 115 · 2014: 149 · 2013: 123 · 2012: 138
FWCI: 3.24
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Neurology Neurosurgery & Psychiatry (publishedVersion)
PubMed Central (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
HighWire Press Open Archive (submittedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
Keywords: Lewy bodies, Parkinson's disease, pathogenesis, neurofilaments, substantia nigra, incidental Lewy body disease, age-related prevalence, neuronal loss
MeSH terms: Adolescent, Adult, Aged, Aged, 80 and over, Brain, Brain Damage, Chronic, Inclusion Bodies, Child, Humans, Middle Aged, Nerve Degeneration, Parkinson Disease, Substantia Nigra

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks